Chase Investment Counsel’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,702
Closed -$221K 149
2024
Q1
$221K Buy
+2,702
New +$221K 0.08% 131